Lataa...
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
Oncolytic viruses (OVs) preferentially infect and kill cancer cells. Additionally, OV-induced immune responses subvert cancer-associated immunosuppression and promote antitumor immunity. We have recently demonstrated that the complementation of oncolytic virotherapy with gemcitabine accentuates its...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4010537/ https://ncbi.nlm.nih.gov/pubmed/24804161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27622 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|